(a, b) GFAP-LepR−/− (−/−) mice showed blunted suppression of feeding in response to leptin administration (Fig. 3a: n=5 mice for GFAP-LepR+/+ (+/+)-vehicle, GFAP-LepR−/−-vehicle and GFAP-LepR−/−-leptin; n=6 mice for GFAP-LepR+/+-leptin, p=0.052, F(1,17)=4.386 for 1 h; p=0.018, F(1,17)=6.873 for 2 h; Fig. 3b: n=6 mice per group, p=0.0095, F(9,36)=2.971). (c) Representative images show double labeled POMC-GFP and Fos cells in the Arc of GFAP-LepR+/+ and GFAP-LepR−/− mice. Scale bar = 100 μm. (d) Number of Fos-positive POMC cells induced by leptin treatment was reduced in GFAP-LepR−/− mice (n=6 slices for GFAP-LepR+/+-vehicle; n=12 slices for GFAP-LepR+/+-leptin; n=13 slices for GFAP-LepR−/−-leptin, p=0.013, t(16)=2.788 for GFAP-LepR+/+-vehicle versus GFAP-LepR+/+-leptin; p=0.0056, t(23)=3.055 for GFAP-LepR+/+-leptin versus GFAP-LepR−/−-leptin). (e, f) GFAP-LepR−/− mice showed increased feeding after fasting or ghrelin administration (Fig 3e: n=6 mice for GFAP-LepR+/+; n=7 mice for GFAP-LepR−/−, p=0.0378, t(11)=2.361 for 1 h; p=0.0092, t(11)=3.150 for 3 h; Fig 3f: n=5 mice for GFAP-LepR+/+-vehicle; n=6 mice for GFAP-LepR−/−-vehicle; n=12 mice for GFAP-LepR+/+-ghrelin; n=11 mice for GFAP-LepR−/−-ghrelin, p=0.04, F(1,32)=4.57). (g) Representative images show double labeled AgRP-GFP and Fos cells in the Arc of GFAP-LepR+/+ and GFAP-LepR−/− mice. Scale bar = 100 μm. (h) Number of Fos-positive AgRP cells induced by overnight fasting was enhanced in GFAP-LepR−/− mice (n=12 slices for GFAP-LepR+/+-fed; n=20 slices for GFAP-LepR+/+-fasted; n=17 slices for GFAP-LepR−/−-fasted, p<0.0001, t(30)=6.721 for GFAP-LepR+/+-fed versus GFAP-LepR+/+-fasted; p<0.0001, t(35)=6.848 for GFAP-LepR+/+-fasted versus GFAP-LepR−/−-fasted). White arrows indicate double-labeled cells. *, p<0.05; **, p<0.01; ***, p<0.001 versus (+/+), leptin or fasted. Results are means ± the s.e.m. P values for unpaired comparisons were analyzed by two-tailed Student's t-test. Two-way ANOVA was performed to detect significant interaction between genotype and treatment (leptin or ghrelin). Two-way repeated measures ANOVA was performed to detect significant interaction between genotype and time (multiple injections of leptin).